Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial.
Saved in:
| Title: | Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial. |
|---|---|
| Authors: | Zeng H; Department of Radiation Oncology, Division of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China; GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Department of Radiation Oncology (Maastro), Maastricht, The Netherlands. Electronic address: haiyan.zeng@maastro.nl., Hendriks LEL; GROW-School for Oncology and Reproduction, Maastricht University Medical Center+, Department of Pulmonary Diseases, Maastricht, The Netherlands., Belderbos J; The Netherlands Cancer Institute, Department of Radiation Oncology, Amsterdam, The Netherlands., Brandts L; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center+, Maastricht, The Netherlands., Compter I; GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Department of Radiation Oncology (Maastro), Maastricht, The Netherlands., Dubois L; The M-Lab, Department of Precision Medicine, GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Holt MG; Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal., Houben R; GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Department of Radiation Oncology (Maastro), Maastricht, The Netherlands., Schagen S; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Zhang X; GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Department of Radiation Oncology (Maastro), Maastricht, The Netherlands., Prezzemolo T; VIB Center for Brain and Disease Research, VIB, Leuven, Belgium; Department of Microbiology and Immunology, KU Leuven-University of Leuven, Leuven, Belgium., De Ruysscher D; GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Department of Radiation Oncology (Maastro), Maastricht, The Netherlands. |
| Source: | Clinical lung cancer [Clin Lung Cancer] 2024 Nov; Vol. 25 (7), pp. 653-659.e1. Date of Electronic Publication: 2024 Aug 22. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
